A company based in Massachusetts is workings towards the generation of a coronavirus vaccine.
As of Sunday, there had been 3 confirmed cases of the newest virus in the United States. The infected individuals were based in southern California, Washington state, and Chicago.
Many thousand Chinese individuals are suffering from the newest disease. Up until now, 56 individuals have passed away from the coronavirus.
An increasing number of nations have reported the occurrence of the coronavirus. These include Japan, Thailand, Taiwan, France, South Korea, Macau, etc.
Moderna, a biotech firm based in Cambridge, Massachusetts, is teaming up with the National Institute of Health to develop a vaccine for the coronavirus.
Researchers are making use of the mRNA technology to guide the immune system to identify a virus that takes control of the cells.
Up until now, the company based in Cambridge has checked this newest platform against numerous viruses in a total of 6 clinical trials. These viruses include influenza.
According to Dr. Tal Zaks, the results confirm how they are able to develop an immune response to identify a particular virus in the body.
Through the mRNA technology, researchers are allowed to quickly respond to possible and incoming health hazards.
The initial step to take is figuring out the perfect vaccine and proving that it can successfully work on a person. This will be carried out in a clinical trial. Following that, they scale up the study to establish how the vaccine is to be provided to the individuals who are most in need of it.